A list of clinical trials available for CS patients:
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
https://www.clinicaltrials.gov/ct2/show/NCT05193188?cond=Chondrosarcoma&draw=2&rank=1
Study of INBRX-109 in Conventional Chondrosarcoma
https://www.clinicaltrials.gov/ct2/show/NCT04950075?recrs=abdf&cond=Chondrosarcoma&draw=2&rank=3
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma (ISG-MCS)
https://www.clinicaltrials.gov/ct2/show/NCT04305548…
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
https://www.clinicaltrials.gov/ct2/show/NCT04340843?recrs=abdf&cond=Chondrosarcoma&draw=2&rank=7
AG-120 in People With IDH1 Mutant Chondrosarcoma
https://www.clinicaltrials.gov/ct2/show/NCT04278781?recrs=abdf&cond=Chondrosarcoma&draw=2&rank=8
Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
https://www.clinicaltrials.gov/ct2/show/NCT02821507?recrs=abdf&cond=Chondrosarcoma&draw=3&rank=11
Testing Atezolizumab in Patients >= 2 Years Old With Newly Diagnosed, Unresectable, or Metastatic Clear Cell Sarcoma or Chondrosarcoma
https://www.clinicaltrials.gov/ct2/show/NCT04458922?recrs=abdf&cond=Chondrosarcoma&draw=3&rank=12
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
https://www.clinicaltrials.gov/ct2/show/NCT04040205…
Phase I Study of IGM-8444 as a Single Agent and in Combination in Subjects With Relapsed and/or Refractory Solid Cancers
https://www.clinicaltrials.gov/ct2/show/NCT04553692…
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas (REGOBONE)
https://www.clinicaltrials.gov/ct2/show/NCT02389244…
IACS-6274 With or Without Pembrolizumab for the Treatment of Advanced Solid Tumors
https://www.clinicaltrials.gov/ct2/show/NCT05039801…
Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
https://www.clinicaltrials.gov/ct2/show/NCT03670069…
Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)
https://www.clinicaltrials.gov/ct2/show/NCT03277924…
TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss (TQBSP)
https://www.clinicaltrials.gov/ct2/show/NCT04690725…
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
https://www.clinicaltrials.gov/ct2/show/NCT03474640…